7-5-4　ⓔ文献

  1. Hibbett DS, Binder M, et al: A higher–level phylogenetic classification of the Fungi. Mycol Res, 2007; 111: 509–547.

  2. Roden MM, Zaoutis TE, et al: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis, 2005; 41: 634–653.

  3. Spellberg B, Edwards J, et al: Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev, 2005; 18: 556–569.

  4. Dimitrios P, Kontoyiannis et al: How I treat mucormycosis. Blood, 2011; 118: 1216–1224.

  5. 深在性真菌症のガイドライン作成委員会：深在性真菌症の診断・治療ガイドライン，2014; 122–123.

  6. Chamilos G, Lewis RE, et al: Delaying amphotericin B–based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis, 2008; 47: 503–509.

  7. Kimura M, Araoka H, et al: Cunninghamella bertholletiae pneumonia showing a reversed halo sign on chest computed tomography scan following cord blood transplantation. Med Mycol, 2012; 50: 412–416.

  8. Chamilos G, Marom EM, et al: Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis, 2005; 41: 60–66.

  9. Jung J, Kim MY, et al: Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis. Clin Microbiol Infect, 2015; 21: 684.e11–e18.

  10. Kontoyiannis DP, Wessel VC, et al: Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis, 2000; 30: 851–856.

  11. Lee FY, Mossad SB, et al: Pulmonary mucormycosis: the last 30 years. Arch Intern Med, 1999; 159: 1301–1309.